This IG will use FHIR to support electronic health data exchange of cancer pathology information between a hospital or facility-based laboratory information system (LIS) and hospital or facility-based electronic health record (EHR) system. The goal of this project is to create one FHIR implementation guide (US Realm) that will be based on NAACCR Standards for Cancer Registries Volume V, Laboratory Electronic Reporting Pathology Version 5, May 2020 (Revised 2020).   

The IG will use the FHIR message bundle paradigm and profile data from NAACCR Volume 5, including MessageHeader, DiagnosticReports, and Specimen. It will be based on US Core profiles where possible, binding to terminologies such as SNOMED CT and the North American Association of Central Cancer Registries Volume II, Data Standards & Data Dictionary. It will also include CAP eCC Protocol CKey Identifier to SNOMED translation. 

Timeline & Status

PSS Consensus Review period2021-01-26 to 2021-03-02
ConnectathonMay 2021

Link to approved NIB


September 2021

Recon Package Approval


ConnectathonMay 2021
ConnectathonJanuary 2022
ConnectathonMay 2022
PublicationFall 2022

Meeting Information

Wednesdays at 10:00 am ET


Microsoft Teams meeting

Join on your computer or mobile app

Click here to join the meeting

Or call in (audio only)

+1 208-996-1659,,939072358#   United States, Boise

Phone Conference ID: 939 072 358#

Find a local number | Reset PIN

Learn More | Meeting options


Project Information

Project Insight Number1686
HL7 Sponsor(s)

Orders and Observations

2021-01-26 Orders & Observations WGM Tuesday Q2

Project Proposal    


Accepted 2021-01-28


2021-03-08 TSC Agenda/Minutes

2021-02-03 FMG Agenda/Minutes

FHIR IG Proposal

FHIR IG Proposal

Approved by FMG: 2021-02-03 FMG Agenda/Minutes

All in favor

May 2021 Connectathon
January 2022 Connectathon

2022-01 Cancer Pathology Reporting to EHRs

*tested in MedMorph track

May 2022 Connectathon2022 - 05 Connectathon 30
September 2022 Connectathon2022-09 Cancer Electronic Pathology Reporting (Cancer FHIR IG & IHE SDC on FHIR) 
Cancer FHIR IG CI Build


O&O (Sponsor WG) Approval

to start publication process

2022-06-23 Main

Ruby Nash/Riki Merrick - In favor: 12, Abstain: 4, Against: 0

FMG Approval of STU Publication Request by the OO WG for HL7 FHIR® IG: Cancer Pathology Data Sharing

Sent out with 9/2 e-Vote, approved by FMG 9/7

2022-09-02 FMG e-Vote#20220902FMGeVote-ballot--1580770162-a

Project Team:

Lantana Consulting Group (IG developers)

Centers for Disease Control and Prevention

  • Sandy Jones, Public Health Advisor, (SFT1@cdc.gov)
  • Caitlin Kennedy, Health Scientist, (mhy5@cdc.gov)
  • Vernellia Johnson, Cancer Surveillance Branch Acting Deputy Director (hft9@cdc.gov)
  • No labels